SUCRALFATE
Generic: SUCRALFATE
Torrent Pharmaceuticals LimitedManufacturer
ORALRoute
SUCRALFATEActive Substance
2024-03-21Original Approval
SUCRALFATE is FDA application ANDA216726, sponsored by ABON PHARMS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2023-08-30
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and DistribuSuperpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Class I2023-10-18
Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and DistMicrobial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Top Reported Reactions
1
NAUSEA
1,473 reports
2
DIARRHOEA
1,067 reports
3
FATIGUE
1,058 reports
4
PAIN
953 reports
5
HEADACHE
934 reports
6
OFF LABEL USE
897 reports
7
DRUG INEFFECTIVE
846 reports
8
VOMITING
844 reports
9
DYSPNOEA
824 reports
10
CHRONIC KIDNEY DISEASE
669 reports